| Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature K Schwarze, J Buchanan, JC Taylor, S Wordsworth Genetics in Medicine 20 (10), 1122-1130, 2018 | 608 | 2018 |
| 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care—Preliminary Report 100,000 Genomes Project Pilot Investigators New England Journal of Medicine 385 (20), 1868-1880, 2021 | 540 | 2021 |
| The challenge of antimicrobial resistance: what economics can contribute LSJ Roope, RD Smith, KB Pouwels, J Buchanan, L Abel, P Eibich, ... Science 364 (6435), eaau4679, 2019 | 481 | 2019 |
| The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom K Schwarze, J Buchanan, JM Fermont, H Dreau, MW Tilley, JM Taylor, ... Genetics in Medicine 22 (1), 85-94, 2020 | 263 | 2020 |
| Issues surrounding the health economic evaluation of genomic technologies J Buchanan, S Wordsworth, A Schuh Pharmacogenomics 14 (15), 1833-1847, 2013 | 128 | 2013 |
| Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions KA Phillips, PA Deverka, DA Marshall, S Wordsworth, DA Regier, ... Value in Health 21 (9), 1033-1042, 2018 | 74 | 2018 |
| Clomifene citrate and intrauterine insemination as first-line treatments for unexplained infertility: are they cost-effective? S Wordsworth, J Buchanan, J Mollison, K Harrild, L Robertson, C Tay, ... Human reproduction 26 (2), 369-375, 2011 | 70 | 2011 |
| Availability and funding of clinical genomic sequencing globally KA Phillips, MP Douglas, S Wordsworth, J Buchanan, DA Marshall BMJ global health 6 (2), e004415, 2021 | 69 | 2021 |
| Valuation of health and nonhealth outcomes from next-generation sequencing: Approaches, challenges, and solutions DA Regier, D Weymann, J Buchanan, DA Marshall, S Wordsworth Value in Health 21 (9), 1043-1047, 2018 | 69 | 2018 |
| Women’s birth place preferences in the United Kingdom: a systematic review and narrative synthesis of the quantitative literature J Hollowell, Y Li, R Malouf, J Buchanan BMC pregnancy and childbirth 16, 1-17, 2016 | 66 | 2016 |
| Addressing challenges of economic evaluation in precision medicine using dynamic simulation modeling DA Marshall, LR Grazziotin, DA Regier, S Wordsworth, J Buchanan, ... Value in Health 23 (5), 566-573, 2020 | 57 | 2020 |
| Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers J Buchanan, S Wordsworth, T Ahmad, A Perrin, S Vermeire, M Sans, ... Journal of Crohn's and Colitis 5 (4), 301-316, 2011 | 57 | 2011 |
| Financing and reimbursement models for personalised medicine: A systematic review to identify current models and future options R Koleva-Kolarova, J Buchanan, H Vellekoop, S Huygens, M Versteegh, ... Applied Health Economics and Health Policy 20 (4), 501-524, 2022 | 45 | 2022 |
| Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom S Wordsworth, J Buchanan, R Regan, V Davison, K Smith, S Dyer, ... Genomic medicine 1, 35-45, 2007 | 42 | 2007 |
| Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies? J Buchanan, S Wordsworth PharmacoEconomics 33 (6), 571-9, 2015 | 39 | 2015 |
| A review of the challenges of using biomedical big data for economic evaluations of precision medicine P Fahr, J Buchanan, S Wordsworth Applied health economics and health policy 17 (4), 443-452, 2019 | 36 | 2019 |
| Toward the diagnosis of rare childhood genetic diseases: what do parents value most? S Pollard, D Weymann, J Dunne, F Mayanloo, J Buckell, J Buchanan, ... European Journal of Human Genetics 29 (10), 1491-1501, 2021 | 35 | 2021 |
| Patients’ Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment J Buchanan, S Wordsworth, A Schuh The Patient-Patient-Centered Outcomes Research 9 (6), 525-536, 2016 | 34 | 2016 |
| Can rapid integrated polymerase chain reaction-based diagnostics for gastrointestinal pathogens improve routine hospital infection control practice? A diagnostic study. L Pankhurst, L Macfarlane-Smith, J Buchanan, L Anson, K Davies, ... Health technology assessment (Winchester, England) 18 (53), 1, 2014 | 31 | 2014 |
| Use of decision modelling in economic evaluations of diagnostic tests: an appraisal and review of health technology assessments in the UK Y Yang, L Abel, J Buchanan, T Fanshawe, B Shinkins PharmacoEconomics-open 3 (3), 281-291, 2019 | 30 | 2019 |
Sarah Wordsworth, PhDUniversity of Oxforddph.ox.ac.uk의 이메일 확인됨